These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 37942622)

  • 1. Structure-based virtual screening and molecular docking approaches to identify potential inhibitors against KIF2C to combat glioma.
    Hussein D; Saka M; Baeesa S; Bangash M; Alghamdi F; Al Zughaibi T; AlAjmi MF; Haque S; Rehman MT
    J Biomol Struct Dyn; 2023 Nov; ():1-14. PubMed ID: 37942622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential inhibitors against
    Gaur V; Kumar N; Vyas A; Chowdhury D; Singh J; Bera S
    J Biomol Struct Dyn; 2023 Dec; ():1-11. PubMed ID: 38149858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided identification of lead compounds as Staphylococcal epidermidis FtsZ inhibitors using molecular docking, virtual screening, DFT analysis, and molecular dynamic simulation.
    Tripathy S; Sahu SK; Azam MA; Jupudi S
    J Mol Model; 2019 Nov; 25(12):360. PubMed ID: 31773394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX.
    Chahal V; Kakkar R
    J Biomol Struct Dyn; 2023; 41(12):5465-5480. PubMed ID: 35735269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of
    Kumar N; Srivastava R; Prakash A; Lynn AM
    J Biomol Struct Dyn; 2020 Jul; 38(11):3396-3410. PubMed ID: 31422761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore based virtual screening, molecular docking and molecular dynamic simulation studies for finding ROS1 kinase inhibitors as potential drug molecules.
    Vanajothi R; Vedagiri H; Al-Ansari MM; Al-Humaid LA; Kumpati P
    J Biomol Struct Dyn; 2022 May; 40(8):3385-3399. PubMed ID: 33200682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
    Lather A; Sharma S; Khatkar A
    Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing against the RNA-dependent RNA polymerase domain of dengue serotype 3 by virtual screening and molecular dynamics simulations.
    Gangopadhyay A; Saha A
    J Biomol Struct Dyn; 2023 Jul; 41(11):5152-5165. PubMed ID: 35642087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor potentially stable conformations from molecular dynamics as a structure-based pharmacophore model for mapping, screening, and identifying ligands-a new paradigm shift in pharmacophore screening.
    Shanmugarajan D; David C
    J Biomol Struct Dyn; 2023 Jul; 41(11):4939-4948. PubMed ID: 35543232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational identification and exploration of novel FGFR tyrosine kinase inhibitors for the treatment of cholangiocarcinoma.
    Kaur A; Mandal D
    J Biomol Struct Dyn; 2023 Oct; ():1-12. PubMed ID: 37897189
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Yang Y; Ji C; Zhong Q; Yan H; Wang J
    J Biomol Struct Dyn; 2023 Oct; ():1-14. PubMed ID: 37904331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach.
    Alotaibi BS; Joshi J; Hasan MR; Khan MS; Alharethi SH; Mohammad T; Alhumaydhi FA; Elasbali AM; Hassan MI
    J Biomol Struct Dyn; 2023; 41(14):6749-6758. PubMed ID: 35965440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for potentially biased epidermal growth factor receptor (EGFR) inhibitors through pharmacophore modelling, molecular docking, and molecular dynamics (MD) simulation approaches.
    Jethwa M; Gangopadhyay A; Saha A
    J Biomol Struct Dyn; 2023 Mar; 41(5):1681-1689. PubMed ID: 35014597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of new small molecule monoamine oxidase-B inhibitors through pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Kumar S; Ayyannan SR
    J Biomol Struct Dyn; 2023; 41(14):6789-6810. PubMed ID: 35983603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating a Library of Flavonoids as Potential Inhibitors of a Cancer Therapeutic Target MEK2 Using in Silico Methods.
    AlZahrani WM; AlGhamdi SA; Sohrab SS; Rehan M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel scaffolds targeting SIRT3 through molecular modeling techniques for the treatment of Hepatocellular carcinoma.
    Maya Ramírez CE; Shokat Z; Sufyan M; Rehman MT; AlAjmi MF; Rather GM
    J Biomol Struct Dyn; 2023 Sep; ():1-10. PubMed ID: 37705289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.